@geron-china.com
物产中大金轮蓝海股份有限公司2014年在深圳证券交易所中小企业板上市,股票简称:物产金轮,股票代码:002722。物产金轮致力于以资本和智本推动工业品细分领域的产业进步与升级,成为工业品细分领域卓越的产业投资集团。
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Geron from China, also known as Geron Corporation, is a leading biotechnology company that specializes in the development of innovative therapies for various diseases, with a focus on oncology. The company was founded in 1990 by Michael West and Robert Nelsen and is headquartered in Menlo Park, California, USA. Initially, Geron focused on developing telomerase inhibitors to treat cancer, with its flagship product being Imetelstat.
However, in recent years, the company has shifted its focus to the development of cell therapies, particularly in the fields of regenerative medicine and immunotherapy. Geron operates on a global scale, conducting clinical trials and research collaborations with various academic institutions, biotechnology companies, and pharmaceutical companies worldwide. Notably, Geron has entered into strategic partnerships with top-tier organizations such as Janssen Biotech (a subsidiary of Johnson & Johnson) and the University of Edinburgh.
In terms of its market position, Geron has established itself as a key player in the field of cell therapies, particularly in the treatment of cancer and degenerative diseases. While the company faces competition from other biotechnology companies in the same space, Geron's innovative therapies and strategic partnerships have helped differentiate it from its competitors. Over the years, Geron has achieved several notable milestones.
In 2013, the company received a Fast Track designation from the U. S. FDA for its lead product candidate, Imetelstat, for the treatment of myelofibrosis.
Additionally, Geron has strengthened its product lineup by expanding its pipeline to include cell therapies for cancer and degenerative diseases. As of the latest update, Geron is actively involved in advancing its cell therapy programs through clinical trials and strategic collaborations. The company is dedicated to improving patient outcomes through the development of innovative therapies.
Geron continues to be a respected name in the biotechnology industry, with ongoing efforts to make significant contributions to the field of regenerative medicine and cancer treatment
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online